{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:35:05Z","timestamp":1790717705376,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.clineuro.2021.106492","type":"journal-article","created":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:47:18Z","timestamp":1610930838000},"page":"106492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Risk factors for ischemic antiphospholipid syndrome: A case-control study"],"prefix":"10.1016","volume":"202","author":[{"given":"Roxana","family":"Matus-Mayorga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Barrera-Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Rull-Gabayet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6809-7337","authenticated-orcid":false,"given":"Eduardo","family":"Aguirre-Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7351-2651","authenticated-orcid":false,"given":"Mart\u00edn","family":"Valdez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Espinoza-Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Ramos-Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Cano-Nigenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Barboza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Merayo-Chalico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Arauz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2021.106492_bib0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.clineuro.2021.106492_bib0010","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.clineuro.2021.106492_bib0015","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.clineuro.2021.106492_bib0020","doi-asserted-by":"crossref","first-page":"18005","DOI":"10.1038\/nrdp.2018.5","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"5","key":"10.1016\/j.clineuro.2021.106492_bib0025","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.3346\/jkms.2020.35.e35","article-title":"Epidemiology of antiphospholipid syndrome in Korea: a nationwide population-based study","volume":"35","author":"Hwang","year":"2020","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.clineuro.2021.106492_bib0030","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jaut.2007.11.011","article-title":"Autoantibody explosion in antiphospholipid syndrome","volume":"30","author":"Shoenfeld","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clineuro.2021.106492_bib0035","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.clineuro.2021.106492_bib0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/B978-0-444-63655-3.00002-8","article-title":"Epidemiology of the anti-phospholipid syndrome","volume":"12","author":"Durcan","year":"2017","journal-title":"Hand Syst. Autoimm. Dis."},{"key":"10.1016\/j.clineuro.2021.106492_bib0045","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1136\/annrheumdis-2014-205663","article-title":"The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review","volume":"74","author":"Sciascia","year":"2015","journal-title":"Ann. Rheumat. Dis."},{"key":"10.1016\/j.clineuro.2021.106492_bib0050","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1177\/0961203314531842","article-title":"Antiphospholipid antibodies in neonates with stroke--a unique entity or variant of antiphospholipid syndrome?","volume":"23","author":"Berkun","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.clineuro.2021.106492_bib0055","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/ene.13499","article-title":"The risk of ischaemic stroke in primary APS patients: a prospective study","volume":"25","author":"Massimo","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.clineuro.2021.106492_bib0060","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clineuro.2021.106492_bib0065","first-page":"1397","article-title":"GAPSS: the global anti-phospholipid syndrome score","volume":"52","author":"Sciascia","year":"2013","journal-title":"Reumathology"},{"key":"10.1016\/j.clineuro.2021.106492_bib0070","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1177\/0961203309106832","article-title":"The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe","volume":"18","author":"Cervera","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.clineuro.2021.106492_bib0075","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/acr.22066","article-title":"On behalf of APS ACTION. Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature","volume":"65","author":"Andreoli","year":"2013","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.clineuro.2021.106492_bib0080","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/bmj.287.6399.1088","article-title":"Thrombosis, abortion, cerebral disease, and the lupus anticoagulant","volume":"287","author":"Hughes","year":"1983","journal-title":"Br. Med. J."},{"key":"10.1016\/j.clineuro.2021.106492_bib0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0961203310395053","article-title":"Antiphospholipid syndrome clinical research task force report","volume":"20","author":"Erkan","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.clineuro.2021.106492_bib0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11926-007-0004-3","article-title":"Neurologic manifestations of the antiphospholipid syndrome","volume":"9","author":"Roldan","year":"2007","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.clineuro.2021.106492_bib0095","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3324\/haematol.2019.221945","article-title":"Seronegative antiphospholipid syndrome: refining the value of \u201cnon-criteria\u201d antibodies for diagnosis and clinical management","volume":"105","author":"Pignatelli","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.clineuro.2021.106492_bib0100","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood-2002-02-0441","article-title":"Lupus anticoagulants are stronger risk factors of thrombosis tan anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature","volume":"101","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clineuro.2021.106492_bib0105","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1182\/blood-2002-11-3334","article-title":"Antib2-glycoprotein I, antiprothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome","volume":"102","author":"Galli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clineuro.2021.106492_bib0110","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clineuro.2021.106492_bib0115","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/keh213","article-title":"Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus","volume":"43","author":"Bessant","year":"2004","journal-title":"Rheumatol. Oxford (Oxford)"},{"key":"10.1016\/j.clineuro.2021.106492_bib0120","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMra1112830","article-title":"The pathogenesis of the antiphospholipid syndrome","volume":"368","author":"Giannakopoulos","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clineuro.2021.106492_bib0125","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S1474-4422(09)70239-X","article-title":"Antiphospholipid antibodies and risk of myocardial infarction and ischemic stroke in young women in the RATIO study: a case-control study","volume":"8","author":"Urbanus","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.clineuro.2021.106492_bib0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1182\/asheducation-2009.1.233","article-title":"Antiphospholipid antibody syndrome","author":"Lim","year":"2009","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.clineuro.2021.106492_bib0135","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11926-011-0223-5","article-title":"The management of stroke in anthiphospholipid syndrome","volume":"14","author":"Panichpisal","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.clineuro.2021.106492_bib0140","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.3389\/fneur.2018.01001","article-title":"Antiphospholipid syndrome and the neurologist: from pathogenesis to therapy","volume":"9","author":"Fleetwood","year":"2018","journal-title":"Front. Neurol."},{"issue":"5","key":"10.1016\/j.clineuro.2021.106492_bib0145","first-page":"1","article-title":"Treatment of the antiphospholipid syndrome","volume":"2914","author":"Galli","year":"2021","journal-title":"Autoimm Highlights"},{"issue":"2","key":"10.1016\/j.clineuro.2021.106492_bib0150","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/0961203310395803","article-title":"Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies","volume":"20","author":"Ruiz-Irastorza","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.clineuro.2021.106492_bib0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11926-016-0566-z","article-title":"Emerging therapies in antiphospholipid syndrome","volume":"18","author":"Andrade","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.clineuro.2021.106492_bib0160","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/rheumatology\/key082","article-title":"CAPS Registry Project Group, the effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients","volume":"57","author":"Rodr\u00edguez-Pint\u00f3","year":"2018","journal-title":"Rheumatology"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846721000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:36:20Z","timestamp":1759588580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846721000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"alternative-id":["S0303846721000196"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106492","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for ischemic antiphospholipid syndrome: A case-control study","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2021.106492","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106492"}}